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Abstract

Chittom, Leeanne M.S. The University of Memphis. May 2012. The Efficacy of an
Intravenous Potassium Repletion Algorithm in Trauma Intensive Care Patients.
Professors: Ruth Williams-Hooker, MS, RD, EdD., Roland N. Dickerson, PharmD, DPh,
Beth Egan, MS, RD.
Low serum potassium, medically known as hypokalemia, is a common
phenomenon in patients sustaining traumatic injuries and head trauma. Maintenance of
potassium homeostasis is imperative to improve outcomes for trauma patients. Mortality
risk increases with severe hypokalemia, defined as serum potassium levels less than 2.5
milliequivalents/deciliter (mEq/dL) (1). It appears there are other variables which affect
serum potassium levels in the presence of mild hypokalemia which may provide the
clinician with a difficult task of achieving desired serum potassium levels of 4.0 mEq/dL.
Variables may include physiological homeostasis, depletion in total body potassium
stores and other unknown factors. Recommendations for repletion of serum potassium
levels in critically ill hospitalized patients is in increments of 10 mEq potassium chloride
(KCL) per hour up to 20 mEq KCL per hour and in severe situations with
electrocardiograph changes up to 40 mEq KCL per hour intravenously (2).
The nutrition support service at The Regional Medical Center at Memphis has
been utilizing an empiric algorithm for potassium repletion for the treatment of
hypokalemia in the Elvis Presley Memorial Trauma Center patients requiring specialized
nutrition support. The purpose of this research is to evaluate the efficacy of this
potassium repletion algorithm. Treatment of hypokalemia is important in critical illness
for maintaining proper cardiac function as well as prevention of muscle paralysis,
arrhythmias and other complications.
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Patients with moderate to severe hypokalemia showed a greater improvement in
serum potassium levels upon receipt of sixty mEq or eighty mEq KCL. Although the
study groups were small for both the moderate to severe hypokalemia groups there was
statistical significance with both treatment groups. The results in the moderate to severe
hypokalemia groups can be attributed to lower total body potassium stores and increased
need for exogenous potassium.
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CHAPTER 1
REVIEW OF LITERATURE
Introduction
Low serum potassium, medically termed hypokalemia, is a common phenomenon
in patients sustaining traumatic injuries. Mortality risk increases with severe
hypokalemia, considered to be serum potassium levels less than 2.5 milliequivalents per
deciliter (mEq/dL) (1). Recommendations for repletion of serum potassium levels in
critically ill hospitalized patients is dosed in increments of 10 mEq potassium chloride
(KCL) per hour up to 20 mEq KCL per hour and in severe situations with
electrocardiograph changes up to 40 mEq KCL per hour intravenously (2). Maintenance
of potassium homeostasis is imperative to improved outcomes for trauma patients.
The nutrition support service at The Regional Medical Center at Memphis has
been utilizing an empiric algorithm for potassium repletion for the treatment of
hypokalemia in the Elvis Presley Memorial Trauma Center patients requiring specialized
nutrition support. The purpose of this research is to evaluate the efficacy of this
potassium repletion algorithm (Table1).
Role of Potassium in the Body
Potassium plays an important role in cardiac and muscle function. It is found in
both intracellular and extracellular fluid with 98 percent of total body potassium found in
intracellular volume, making it a major intracellular cation. A delicate balance occurs
between the intracellular and extracellular fluid compartments; very small shifts can have
a large impact on total plasma levels. Extracellular potassium concentration impacts
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balance in two ways is total body potassium content and relative distribution of
potassium to intracellular and extracellular fluid compartments.
The first way is total body potassium content is determined by the difference
between potassium intake and excretion. Equilibrium occurs when the amount of
potassium ingested equals the amount excreted. Intake varies according to diet but the
kidneys handle 90% of output while the rest is excreted into bowel and is eliminated in
feces. Upon ingestion, potassium is quickly absorbed and moved into circulation via
portal circulation. Once in portal circulation, potassium stimulates secretion of insulin
which acts on the Na-K-ATPase pump to facilitate the entry of potassium into cells (3).
A secondary mechanism for maintenance of intracellular potassium balance is
distribution of potassium between organs and extracellular tissue. This distribution is
regulated by many hormones and acid-base balance and tonicity of plasma. On the other
hand, an enzyme located in the cell membrane allows potassium to move against an
electrical gradient and pumps potassium out of the cell in exchange for sodium. In steady
state, the rate of active potassium transport into the cell is equal to the rate of passive
diffusion of potassium out of the cell (4).
Imbalances in potassium levels can have profound effects on patients.
Hyperkalemia, considered to be serum potassium of > 5 mEq/dL, can have a catastrophic
effect on the human body. Serious consequences of hyperkalemia include impaired
cardiac function with arrhythmias, peaking Terahertz radiation (T waves) and widening
of series of wave forms: negative Q wave before positive R wave followed by the S
wave by negative deflection after an R wave on electrocardiogram (QRS complex).
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Paralysis occurs once serum potassium levels consistently reach greater than 7.5mEq/dL
(3).
Hemolysis is a common cause of hyperkalemia. Pseudo-hyperkalemia results
from improper blood specimen collection, transport or in processing the specimen. When
this happens, patients are treated for a false diagnosis of hyperkalemia.
Acid-base disturbances are associated with hyperkalemia, primarily acidosis. In
the presence of acidosis, potassium ions are pushed out of the cells due to intracellular
influx of hydrogen ions. Acidosis increases serum potassium due to pushing potassium
out of the cell to maintain electrical balance. Alkalosis decreases serum potassium by
pushing potassium back into the cell and increasing urinary potassium excretion. A
common rule of thumb to determine the inverse relationship between potassium and pH
is every 0.1 drop in pH results in a 0.6 rise in potassium. However, a more accurate
description of the change in serum potassium is a 0.4 to 1.3 mEq/L for every 0.1 change
in pH (4,5).
Other causes of hyperkalemia are acute or chronic kidney disease (CKD), diabetes
(DM), advanced age, and medications which may perpetuate elevations in serum
potassium (6). In kidney disease, secretion is decreased due to diminishing renal cell
mass; unfortunately, this process is further complicated as the renal function worsens
limiting amounts of potassium secreted. Hyperkalemia in diabetics is related to
reduction in insulin or lack of insulin production which prohibits potassium movement
into cells. Primarily this occurs in diabetics with poorly managed disease or increased
insulin resistance resulting in prolonged hyperglycemia which leads to impaired renal
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function. As a person ages, normal organ function is reduced; and medications can
exacerbate the effects on potassium balance.
Medications cause hyperkalemia by impairing secretion of potassium or
increasing the level of potassium in the body. Potassium sparing diuretics such as
spironolactone or triamterence inhibit renal potassium excretion. Potassium containing
antibiotics such as penicillin-G potassium (Pen-G K) provide 1.68 mEq per million units
of potassium. Initially this quantity of potassium appears small; however, a patient may
receive 32 mEq to 160 mEq potassium over twenty-four hours which could cause
hyperkalemia (7,3).
Other classes of medications which impact potassium balance include
agiontensin-converting enzyme inhibitors (ACEI), non-steroidal anti-inflammatory drugs
(NSAIDS) and heparin. Angiotensin-converting enzyme inhibitors reduce aldosterone
levels in individuals with both normal and impaired renal function. Therefore, potassium
intake should be monitored routinely to ensure serum levels do not become elevated.
Nonsteriodal anti-inflammatory drugs (NSAIDS) suppress renin and aldosterone
secretion by inhibiting prostaglandin synthesis (3). Renal blood flow is reduced and
prostaglandin synthesis is decreased, which affects synthesis of aldosterone thus causing
hyperkalemia. Heparin can induce hyperkalemia due to suppression of aldosterone and
reduction in affinity of angiotensin II receptors in the adrenal gland. Hyperkalemia is a
rare side effect of heparin occurring after several days of therapy; usually in those
persons with underlying renal impairment or diabetes (7).
Although hyperkalemia can have deadly results, hypokalemia is just as
detrimental especially since it is more common than hyperkalemia. Most laboratories
4

would consider potassium of 3.5-5.0 mEq/dL normal. However, symptoms of
hypokalemia may not manifest until serum potassium is <2.5mEq/dL. The most common
complications of hypokalemia include muscle paralysis, arrhythmias, gastrointestinal
ileus, and rhabdomyolysis. Most significantly, cardiac death can occur if hypokalemia is
severe enough or left untreated (2,3,4).
There are many factors which may contribute to hypokalemia. The most common
factors are increased losses of potassium through the kidney and gastrointestinal tract.
Secondary causes are related to rapid influx of potassium into the cell during use of
insulin infusions, a sudden rise in pH, or metabolic alkalosis related to gastrointestinal
losses, or decreased renal perfusion from hypovolemia or heart failure. Tertiary causes
include hypomagnesemia, theophylline toxicity, delirium tremens, and digitalis toxicity
(3).
Potassium and Trauma Patients
In trauma patients, hypokalemia has resulted from beta adrenergic stimulation of
the sodium-potassium adenosine triphosphatase pump (Na-K-ATPase) due to large
release of catecholamines after an injury. The incidence of hypokalemia in trauma
patients is 50 to 68 %. The greater the number of organ systems injured; the higher
incidence of hypokalemia and increased mortality (1). Hypokalemia is also a result of
increased gastrointestinal losses and increased blood loss from trauma and surgery.
Initially, critical care specialists believed that hypokalemia occurs upon initial
injury but normalized within the first twenty-four hours of critical care without requiring
potassium repletion. In patients with blunt, penetrating abdominal trauma, or liver
injuries, it has been suggested that potassium losses are a result of β-adrenergic stimulus
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both pre-operatively and post-operatively (8). Similar suggestions have also been made
for those patients with traumatic brain injury (TBI) (9). Hypokalemia may also relate to
age, arterial pH and serum catecholamine levels (6).
Researchers challenged the theory of early hypokalemia, finding symptoms occur
beyond the initial admission and continuing longer than the first forty-eight hours of
admission into the hospital (9). It is suggested, that hypokalemia is not resultant of
administration of potassium containing intravenous fluids or blood products (10).
Trauma patients sustaining TBI have a greater incidence of hypokalemia occurring
beyond the first twenty-four hours of admission and continue more than one week after
injury. Those patients with TBI not only required more potassium, but also remained
hypokalemic longer in comparison with their non-traumatic brain injured counter parts
(9).
Pampolini investigated the incidence of hypokalemia in pre-operative and post
operative abdominal trauma patients (8). Plasma potassium, sodium, calcium, and
chloride were evaluated before and after surgery in 123 patients with injuries consisting
of hepatic trauma (n=16), spontaneous liver rupture (n=3), extra hepatic trauma: spleen
(n=23), mesentery (n=12), multiple trauma (n=12), ruptured abdominal aortic aneurism
(n=8), hepatic resection (n=19), extrahepatic abdominal organs in patients presenting
some abnormalities in liver function (n=15) and diagnostic laporatomy (n=15). These
patients were matched with non-traumatically injured patients with ages ranging from 4
to 64 years. Results from the study revealed 15 out of 16 patients with hepatic trauma
had normal serum potassium pre-operatively, but sustained drastic decreases in serum
potassium post-operatively (p<0.001). There were no significant differences in plasma
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sodium, calcium, and chloride levels between pre-operatively and post-operatively.
Plasma potassium levels continued to fall dramatically in those patients who underwent
hepatic resection. Additionally, serum glucose levels remained normal to upper limits of
normal, and blood pH levels were also stable. Thus the investigators hypothesized that
hypokalemia could not be attributed to a bowel wasting of the cation or to urinary losses
due to frequent reduction in urine output due to hypotension. However, according to
Pampolini results couldn’t be completely quantified due to need for surgery or other
procedures which impeded 24-hour urine collection for potassium content.
Pampolini concluded hypokalemia could be attributed to shift in potassium from
the blood stream into the intracellular space.

Plasma chloride levels and pH were

reported as normal. The investigators suggested that reasons for the presence of
hypokalemia following hepatic vs. abdominal injuries were intrinsically related to the
liver as it contains greater amounts of adrenergic endings. Epinephrine is known to lower
serum potassium levels via stimulation of beta-adrenoceptors, which induce the uptake of
potassium by the liver and skeletal muscle. The authors in this study inferred the
norepinephrine released by the liver acts with a similar mechanism. It was noted that the
potency of norepinephrine is less than epinephrine; when large amounts of
norepinephrine are released locally, the scarce receptor affinity can be overwhelmed so
that epinephrine-like effects result. Most of the norepinephrine release occurs locally so
a majority of hypokalemia is related to uptake by the liver due to the large size of this
organ. The persistence of hypokalemia goes beyond the short half- life of norepinephrine
and may be explained by an increase in plasma aldosterone. In addition to raising
urinary excretion of potassium, aldosterone also enhances the shift of potassium from the
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blood into the cells. The increase in plasma aldosterone levels is a consequence of
enhanced rennin release due to adrenergic stimulation and possibly a selective
impairment of the hepatic metabolism of the hormone, due to accidental or surgical injury
to the liver. Investigators ruled out insulin as a contributor of hypokalemia for multiple
reasons. Norepinephrine inhibits release of insulin; higher than normal levels of plasma
insulin are needed to shift blood potassium into the intracellular space and the hepatic
neurogenic contribution to glycogenolysis is poor and the consequences are small.
Additionally if insulin is released in response to the intra- and/or postoperatively infused
glucose, an overlapping hypokalemia should be observed in patients undergoing
extrahepatic abdominal operations or diagnostic laporatomy. In summary, the authors
stated the incidence of hypokalemia in pre-operative and postoperative abdominal trauma
patients gave rise to the following considerations. It is mandatory to serially and
frequently control hypokalemia to reduce risk of onset of dangerous arrhythmia
especially in patients receiving digoxin. In 20-30 percent of cases of liver trauma, the
clinical picture is blurred; a mild pain at the upper right abdomen associated with
hypokalemia may be indicative of a lesion on the liver (8). Early accurate diagnosis is
imperative in order avoid hypokalemia.
More recently Vanek et al. studied the pathophysiology of changes in serum
potassium levels in trauma patients (11). The study consisted of 133 trauma patients,
ages 2-88 years in the study group; 59 patients were enrolled in the control group with
ages ranging from 16- 87 years. Most of the study participants and control participants
were males; only 30 patients in the study were female with 9 female patients in the
control group. Traumatic injuries consisted of blunt and penetrating trauma with the
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number of systems injured ranging from one to three systems. Variables recorded upon
admission to emergency room (ER) were systolic blood pressure (SBP), Champion
trauma score, arterial pH, spot urine for potassium and serum potassium (K1), glucose,
alcohol, and catecholamine levels. About 24 hours after admission, spot urine potassium
and serum potassium (K2) and catecholamine levels were recorded as well as the
approximate amount of potassium given during the first 24 hours after admission. Other
variables recorded were age, sex, mechanism of injuries, organ systems injured, lowest
SBP, estimated blood loss (EBL) in the first 24 hours of injury and Injury Severity Score
(ISS). Patients in the control group were selected based upon admission for elective
inguinal hernia repair as these patients were predominantly male and had serum
potassium levels measured as a part of routine preoperative evaluation. Patients excluded
were those with burn injuries, patients receiving diuretic therapy or medications that can
affect serum potassium levels and those patients with hemolyzed blood specimens. The
group differences were expressed in t tests and chi-square tests. The association of serum
potassium and putative risk factors were assessed using t tests and Pearson’s correlation
coefficients. Least squares multiple regressions was used to identify the subset of
variables that best predicted serum potassium while controlling potential cofounding
between the independent variables in the model (11).
Results of the Vanek study revealed there was no significant difference between
the two groups; however, the control group was significantly older than the study group.
The study group had a lower mean K1 (3.55 ± 0.44 vs. 3.95 ±0.34) and higher incidence
of hypokalemia (50% versus 10%) than the control group. Hypokalemia was defined as
serum K<3.6 mEq/L. The difference between the group’s serum potassium levels
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persisted when they were broken down by age. K1, K2, and approximate amount of
potassium administered in the first 24 hours were recorded in 91 patients. The mean K1
was 3.56 ± 0.53 mEq/L, and the incidence of hypokalemia was 47%. K2 was drawn
approximately 24 hours later averaging 4.03 ± 0.39 mEq/L, and the incidence of
hypokalemia was only 9%. Both K2 and incidence of hypokalemia at 24 hours differed
significantly from initial levels and were similar to the control group’s values. The
authors used a standard nomogram to predict total body potassium content based on
serum potassium and pH. Approximately 204 mEq of potassium is necessary to increase
serum potassium from 3.6 to 4.0mEq/L. However, the mean amount of potassium given
to this subgroup was only 38 ± 37 mEq. There was no statistical difference in the serum
catecholamine levels of the study group (11).
In conclusion, the Vanek study found that hypokalemia was significantly more
common in trauma patients with an incidence of 50% of study subjects and only 10% of
control subjects. Although the reason was unclear to the authors, they alluded to the fact
that the change in serum potassium levels occur frequently. Hyperkalemia is believed to
be less common in trauma patients as confirmed in Vanek et al study. Hyperkalemia is
typically seen in cases of shock, hypo-perfusion and acidosis due to the extracellular shift
of potassium. However, it should be noted that low systolic blood pressure did not
correlate with serum potassium levels. In addition, the results yielded conflicting
relationships between the arterial pH, admitting SBP, and TS with initial serum
potassium levels. Soft tissue injury followed by the release of potassium from damaged
cells is a factor in hyperkalemia. Researchers found this factor to have no significant
difference between patients with or without musculoskeletal injuries. Nevertheless,
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hypokalemia occurs quickly and resolves just as rapidly as incurrence of injury. Vanek et
al. did validate previous data reporting the incidence of hypokalemia occurring in more
than 50% of trauma patients and that this phenomenon was more common than
hyperkalemia. It was also noted upon reviewing incidence of hypokalemia based upon
organ systems that there was no significant difference in their patient population despite
the fact that 60% of their patients were admitted with multiple organ systems injury.
While the actual cause of hypokalemia in trauma patients remains unknown, it appears to
be related to an intracellular shift of potassium. This conclusion is supported by the
rapid onset and resolution of serum potassium levels without significant exogenous
potassium replacement. Thus, it appears hypokalemia in trauma patients occurs due to
multiple factors; however, the exact mechanism remains unclear (11).
Studies of Potassium Repletion in Trauma Patients
In order to maintain optimal potassium balance in hospitalized patients, a study
conducted by Kruse and colleagues evaluated the optimal tolerance of short-term
intravenous potassium infusions up to 40 mEq potassium chloride (KCL) per hour (13).
This study showed that repletion via central or peripheral infusion sets was acceptable
with caution that phlebitis may occur with peripheral administration (13). Kruse’s study
looked at effects of individual short term potassium infusion sets at a rate 20 mEq/hour.
1463 infusions were reviewed, 111 were excluded due to the fact that post-infusion
potassium levels were obtained outside 12 hours of infusion. Consequently, a total of
1351 infusions were reviewed. The total number of patients in the study was 190; all
were admitted to the intensive care unit due to medical illnesses ranging from respiratory
failure, shock, renal failure, diabetic ketoacidosis, heart failure, and other medical
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illnesses. Mean pre-infusion potassium was 3.2 mEq/L with average post infusion
potassium 3.8 mEq/L. There were 10 instances of hyperkalemia defined by the study as
serum potassium levels of 5.3 to 6 mEq/L. All potassium was given intravenously with
no documented changes in electrocardiographs (ECG). Kruse recommended dosing short
term intravenous potassium via central or peripheral routes at rates of 20 mEq/ hour in
the intensive care setting but cautioned that cardiac monitoring should be used (13).
Additionally, Kruse evaluated short term intravenous infusions of 20 mEq
potassium chloride in 100 ml normal saline over one hour (14). Forty patients were
enrolled in the study, 19 female and 21 male with a mean age of 59 years. Exclusion
criteria were those patients already receiving enteral or parenteral nutrition,
antiarrhythmic drugs, and diuretics, catecholamines, or sodium bicarbonate. Monitoring
was conducted for electrocardiographs (ECG); one hour before potassium infusion and
again during the infusion of potassium. Serum potassium levels were obtained in 15
minute intervals upon initiation of the potassium infusion as well as 45 minutes post
infusion via arterial catheters. Mean plasma potassium was 2.9 mEq/L at baseline; all
other serum values varied from baseline post infusion by ANOVA (P < 0.001) and
Dunnett’s test (P < 0.001). Peak potassium was 3.5 mEq/L with mean post infusion
change in potassium 0.48 mEq/L. Average change in pH was 0.01± 0.005. Cardiac
rhythm showed normal sinus rhythm in 29 patients, atrial fibrillation in two patients and
multifocal atrial tachycardia in one patient. There were no significant changes in ECG
from baseline to infusion; however, the frequency of premature ventricular complexes
(PVCs) decreased during infusion. The authors concluded the infusion of 20 mEq KCL
over an hour is safe for patients with peak potassium levels climbing towards the
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midpoint or two thirds from completion of the infusion; however, levels dropped back
down very rapidly upon completion. Kruse hypothesized that this drop is due to
homeostatic mechanism, but there was no evidence of hyperkalemia post-infusion. The
researchers didn’t allude to the fact that the patients entered into this study had significant
hypokalemia; thus, one would anticipate an infusion of 20 mEq KCL per hour to be
acceptable evidenced by the serum potassium level falling back down towards low
normal ranges of serum potassium 3.5mEq/L. The authors provided evidence regarding
improvement of PVCs which is symptomatic of severe hypokalemia; therefore, the data
presented would lead one to believe infusing 20mEq KCL over one hour would be an
acceptable practice (14).
Hamill completed a small study consisting of 48 patients in the intensive care
unit, ages 29 to 86 years, concentrating on the safety and efficacy of short term
intravenous potassium infusions (2). The criteria for admittance in the study was serum
potassium of < 3.5mEq/L. Primary diagnosis to the intensive care unit was postoperative
cardiac surgery (n=9), sepsis and multiple organ system failure (n=9), complicated
myocardial infarction (n=7) and respiratory failure (n=5). Potassium infusion
interventions were provided in increments of 20mEq, 30mEq, and 40 mEq in 100 ml
normal saline infused over one hour and were administered to patients for serum
potassium levels of <3.2 but >3.2 mmol/L (n=26), 3.0 to 3.2 mmol/L (n=11, and <3
mmol/L (n=11). Urine and serum potassium were collected during infusion and one hour
post infusion. All patients tolerated infusions without evidence of ECG changes or new
dysrhythmia requiring intervention. The mean highest potassium level achieved was 0.5
± 0.3 mEq/L, 0.9 ± 0.4 mEq/L and 1.1 ± 0.4 mEq/L in the 20 mEq, 30 mEq, and 40 mEq
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groups respectively with maximum serum potassium levels at the completion of infusion.
These results were statistically significant (p < 0.5). Urinary potassium excretion was
increased in all groups during infusion but most significantly in the 30 mEq and 40 mEq
infusion groups respectively. The authors concluded all three dosing schemes were safe
over a one hour infusion time. However, they noted that long-term efficacy of the
potassium received was not studied. This patient population was somewhat similar to
trauma patients; but unfortunately as it pertains to this research, patients were primarily
medical intensive care patients (2).
A more recent study reviewing the influence of traumatic brain injury (TBI) on
serum potassium and phosphorus homeostasis in critically ill multiple trauma patients
was conducted to ascertain if TBI patients require more aggressive repletion of potassium
and phosphorus(9). For the discussion of this review, the results of potassium infusion
were examined. The researchers studied 50 patients; 25 multiple trauma patients and 25
TBI patients receiving mechanical ventilation without renal impairment who were
admitted into the trauma intensive care unit or to the neurotrauma intensive care unit for
the first 14 days of admission. The TBI patients’ mean age was 33 ± 12 years compared
with trauma patients without TBI 42 ± 17 years. Additionally, the TBI patients had a
lower weight 79 kg ± 16 versus 94 kg ± 27. The admission Glasgow Coma scale was 6 ±
2 TBI versus 10 ± 4 in patients without TBI. Injury Severity Scores (ISS) in those
patients with TBI were higher, 33 ± 2 versus 29 ± 2 in those non-TBI patients. Target
serum potassium concentration was 4 mEq/dL. Although they had a greater mean
potassium intake, serum potassium levels were consistently lower in the TBI patients (P
< 0.001). Hypokalemia was defined as serum potassium <3.5 mg/dL with short term
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potassium infusion dosing for serum levels of 3.5 to 3.9 give 40 mEq KCL, 3 to 3.4 give
80 mEq KCL, and <3 give 120 mEq KCL. Even though TBI patients received more than
twice the amount of potassium of non-TBI patients their mean serum potassium
concentrations never reached goal potassium level 4 mEq/dL. On the contrary more than
50 % of the non-TBI patients achieved target serum potassium (P < 0.002). The study
suggested that further investigation should be conducted to determine if more aggressive
dosing of potassium is warranted in these patients (9).
Hypokalemia in trauma patients is very common due to severity of injury, lower
systolic blood pressure, and intracellular cation shifts with normal renal potassium
excretion. Incidence of hypokalemia occurs in greater than half of trauma patients (5).
Low potassium can be attributed to tachycardia and decreased myocardial contraction as
a result of increase stimulation of beta 2-adrenergic receptors by catecholamine. It has
recently been found those trauma patients with TBI require two times the amount of
potassium for the treatment of hypokalemia. In a study by Lindsey et al., non-TBI
trauma patients achieved potassium homeostasis within the first week of therapy;
however, the TBI patient required additional aggressive potassium therapy for greater
than two weeks without achieving targeted serum potassium of 4.0mEq/L (9). Studies
have reflected the benefits of normalizing potassium levels. There have been suggestions
as to how much potassium to give at a single short-term infusion and acceptable routes of
delivery either oral or intravenous. There is a need to investigate efficacy of potassium
dosing schemes or algorithms used to replace serum potassium levels and to determine if
desired results are achieved.
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The purpose of this study was to determine the efficacy of the short term
intravenous dosing algorithm used by the nutrition support service at the Regional
Medical Center at Memphis for trauma patients requiring specialized nutrition support
who are admitted to the Elvis Presley Memorial Trauma Center. The goal was to achieve
serum potassium of 4.0mEq/L utilizing potassium short term infusion guidelines of the
nutrition support service. The dosing algorithm is mild hypokalemia or serum potassium
3.5 -3.9 mEq/L give 40mEq potassium, moderate hypokalemia or serum potassium >33.4 mEq/L give 60 mEq potassium, and for severe hypokalemia or serum potassium <3
mEq/L give 80 mEq potassium.
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CHAPTER 2
METHODS
Subjects
This study is a retrospective chart review of 57 patients admitted to Elvis Presley
Memorial Trauma Center between February 2008 and February 2011. Inclusion criteria
are those patients between the ages of 18 and 65 years requiring specialized nutrition
support for greater than seven days. Patients without acute kidney injury, defined as
serum Creatinine <2mg/dL, as those with acute or chronic kidney injury require lower
potassium dosing. Other patient demographics collected included Glasgow Coma Scale
(GCS), arterial pH, admitting white blood cell count (WBC), admitting cortisol levels as
well as serum albumin, serum pre-albumin, admitting lactate and amounts and frequency
of as well as amounts of packed red blood cells (PRBC). Lastly, serum glucose levels
and finger stick glucose levels were recorded as well as the quantity of insulin received.
Patients were excluded if they had a history of taking or were taking scheduled
medications which are known to significantly alter potassium homeostasis. These
medications include diuretics, angiotensin-converting enzyme inhibitors, beta-2 agonists,
octreotide or oral calcium supplementation, angiotensin-II receptor blockers,
trimethoprim, continuous heparin infusion, nonsteroidial anti-inflammatory agents, or
amphotericin B. Additionally, exclusion criteria included those patients admitted under
the age of 18 or over the age of 65 years, those with thermal injury or HIV/ AIDS.
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Procedure
Pre-infusion serum potassium levels were recorded on patients in the study, as
well as pH, serum glucose, blood urea nitrogen (BUN), serum creatinine, serum
magnesium, and quantity of magnesium received if infusion required. Evaluation of post
infusion potassium levels were recorded to determine positive or negative response to the
quantity of potassium received. Additional data collected included intake and output
volumes on enteral and/or parenteral volume received, volumes of nasogastric output,
and stool volumes when diarrhea was present. Medications to be evaluated due to the
potential effect on serum potassium levels included insulin, such as regular human insulin
utilized for short term glucose management as well as intravenous regular human insulin
infusion volumes, and intermediate or long term insulin administration.
Statistical Analysis
Three analysis of variance tests (ANOVA) were conducted using Sigma Plot
version 11.2 for Windows. Data analyzed were dose responses to 40 mEq, 60 mEq and
80 mEq KCL based upon dose per kilogram body weight, change in potassium (K) with
p= < 0.050. Linear regression was also utilized to determine the relationship between K
dose and change in serum K.
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CHAPTER 3
RESULTS

The population demographics for all three groups were very similar, in age, sex,
BMI and mode of injury. Group one was larger in number of patients (n=40) and more
patients who were male (n=35) (Table 2). The larger number of male subjects to female
subjects in trauma patients is not uncommon; it is typically males with more physically
demanding jobs and usually to participate in more high risk activities. Groups two and
three only contained 8 patients each; both were also evenly distributed male to female
patients (Table 4, 5). The patients in group three were slightly younger and slightly
lower weight than previous two groups but not significant to study.
The treatment of mild hypokalemia using a single short term infusion dose of 40
mEq KCL resulted in no significant or statistical changes in serum potassium levels
(Table 3). Pre-infusion serum potassium levels were 3.7 ±0.26 standard deviations with
post infusion level 3.7 ± 0.36 with a 95% confidence interval. The group was large
enough (n=41) to reflect any variables in the sample. There was no change observed
between the subjects’ weight, serum potassium level and dose of intravenous potassium
provided.
For the second treatment group with moderate hypokalemia ( n= 8), patient
demographic were similar to group one more male and female patients (Table 4). The
patients weighed the same and they were similar in race. Serum potassium levels were
lower which supported a higher dose of KCL. There was a clinically significant
response to a short term infusion of 60 mEq KCL with p = 0.163. Potassium response
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to 60 mEq potassium dose resulted in a clinically relevant increase in potassium (Table
3). This increase was statistically significant with 95% confidence interval for
difference of means 0.591 to 0.0657. The findings indicated a 0.26 point rise in serum
potassium after administration of 60 mEq KCL dose. This rise could be due to chance
related to the small study group; however, it cannot not be ruled out as actual response
to short term infusion of potassium chloride due to the positive response.
The final treatment group of 80 mEq potassium chloride dose (n=8) these
patients were slightly younger than the previous two groups and lower weight (Table 4).
Their serum potassium level was much lower than previous which justified the dose of
potassium administered. For the treatment of moderate to severe hypokalemia
achieved statistical significance (p= 0.467) with 95% confidence interval for difference
of means 1.110 to 0.05153 (Table 4). Although the study group was small (n=8), the
response to the short term infusion reflected a rise in serum potassium by 0.6 mEq/dL.
Thus, the response to 80 mEq KCL short-term infusions is greater than what would be
expected by chance (p= 0.045).
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CHAPTER 4
DISCUSSION

In group one treatment of mild hypokalemia, it appears that 40 mill-equivalents
(mEq) potassium chloride does not make a significant impact towards achieving target
serum potassium levels of 4.0 mEq/dL based upon mean pre-infusion potassium levels
3.6 ±0.2 mEq/dL standard deviations. Post infusion potassium levels were 3.7 ±0.4
mEq/dL standard deviations. The difference between the two groups was 0.07 with a
confidence interval 0.189 to 0.0474. The 40 mEq KCL group did not reflect change in
serum potassium (p<0.50). The limited response may be reflective of physiological
variables to maintain homeostasis. The treatment group failed to show a significant
change in serum potassium p= 0.233 target p< 0.050; therefore it cannot be ruled out the
change was due to chance. The population size did not contribute to failure of the results
in this study group.
In group two, moderate hypokalemia, the mean pre-treatment serum potassium
levels were 3.5 ± 0.2 standard deviations and post treatment serum potassium levels of 3.8
± 0.3 standard deviations. The difference between the two groups was 0.263 with seven
degrees of freedom. The population was small, containing only 8 patients; however,
providing a short term infusion of 60 mEq KCL proved beneficial in treatment of moderate
hypokalemia (p= 0.163) and 95% confidence interval. The change that occurred with the
treatment is not great enough to exclude the possibility that the difference is due to chance.
60 mEq KCL short term infusion appears to be advantageous in improving serum
potassium levels.
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The most significant improvement in serum potassium levels via short term
infusion was found in the severe hypokalemia group three with serum potassium levels
<3.5 mEq/dL. Mean pre-infusion potassium was 3.3 mEq/dL ± 0.1 standard deviations
and mean post infusion potassium level 3.9 mEq/dL ± 0.6 standard deviations. This
treatment group had statistical significance (p=0.467). The difference was 0.563 with 95
percent confidence interval and seven degrees of freedom (p=0.045). The change which
occurred with the treatment achieved desired result is greater than would be expected as
evidenced by p=0.045.
Further analysis was conducted comparing each dosing regimen to the next;
however, this analysis failed to pass (p<0.050) but passed equal variance test (p=0.423).
Upon comparing 40 mEq KCL dose (group 1) to 80 mEq KCL dose (group 3), the
difference between the means was 0.492 with p= 0.011. When compared between the 60
mEq KCL dose (group 2) to 80 mEq KCL dose, there was no difference between the two
groups (P<0.050). Similarly, when group 1 was compared to group 2, there was no
difference between the two groups (p<0.050). The difference between the mean values
among the treatment groups one and three are greater than would be expected by chance
resulting in a statistically significant difference (p=0.031).
The treatment of hypokalemia is important in critical illness for maintaining
proper cardiac function as well as prevention of muscle paralysis, arrhythmias and other
complications. It appears there are several variables which affect serum potassium levels
in the presence of mild hypokalemia which may provide the clinician with a difficult task
of achieving serum potassium levels of 4.0. These variables may include physiological
homeostasis, less depletion in total body potassium stores and other unknown factors.
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The results of the study indicated that there is benefit to higher potassium dosing
for the treatment of moderate to severe hypokalemia as reflected in the results showing
greater improvement in overall serum potassium levels. Although the study groups were
small for both the moderate to severe hypokalemia groups, there was statistical
significance for higher potassium chloride dosing with both treatment groups. The
results in the moderate to severe hypokalemia groups can be attributed to lower total
body potassium stores and increased need for exogenous potassium.
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GLOSSARY

1. Arrhythmias: Irregular heartbeats, caused by cardio vascular disease, electrolyte
disturbances: sodium and potassium, changes in heart muscle or heart attack such
as premature ventricular contractions (PVCs), atrial fibrillation, premature atrial
contraction, prolonged QT syndrome and tachycardia.
2. Exogenous: introduced from or produced outside the organism or system
3. Homeostasis: a normal state of balanced and stable internal environment, which
can vary slightly to accommodate external changes.
4. Empiric: Pertaining to a method of treating disease based on observations and
experience without an understanding of the cause or mechanism of the disorder or
the way the therapeutic agent or procedure affects improvement or cure.
5. Plasma: Liquid portion of blood; contains water, proteins, salts, nutrients,
hormones, and vitamins
6. Portal Circulation: circulation of blood through larger vessels from the capillaries
of one organ to those of another; applied to the passage of blood from the
gastrointestinal tract and spleen through the portal vein of the liver.
7. Na-K-ATPase pump: Sodium-Potassium-Adenosine triphosphatase pump: a
complex in the plasma membrane catalyzing the approximate reaction (Na+ + K+)
- ATPase and Na+, K+ ATPase. Sodium and potassium concentrations in cells are
maintained by pumping Na out of the cells and K into cells (against their
concentration gradients) at the expense of ATP hydrolysis.

26

8. Acid-base balance: A means of maintaining balance between hydrogen ions
within the body.
9. Tonicity: State of tissue tone or tension, or the effective osmotic pressure
equivalent.
10. Electrical gradient: a measure of electrical change over a specific quantity
11. Influx: Act of flowing in
12. pH: the symbol relating the hydrogen ion concentration or activity of a solution to
that of a given standard solutions. pH is approximately equal to the negative
logarithm of hydrogen concentration expressed in molarity.
13. Aldosterone: main mineralocorticoid hormone secreted by the adrenal cortex, the
principle biological activity of which is the regulation of electrolyte and water
balance by promoting the renal retention of sodium and the excretion of
potassium.
14. Angiotensin: a polypeptide present in the blood and formed by the catalytic action
of renin on angiontensinogen in the blood plasma.
15. Angiotensin-II: an octapeptide hormone, powerful vasopressor and stimulator of
aldosterone secretion by restricting pressure and diminishes fluid loss in the
kidney by restricting flow.
16. Gastrointestinal ileus: Obstruction of the intestines
17. Rhabdomyolysis: disintegration or dissolution of muscle, associated with
excretion of Myoglobin in the urine.
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18. Metabolic alkalosis: a disturbance in which the acid-base status of the body shifts
toward the alkaline side because of retention of base or loss of noncarbonic or
nonvolatile acids.
19. Delirium tremens: an acute, reversible organic mental disorder characterized by
reduced ability to maintain attention to external stimuli and disorganized thinking
as manifested by rambling, irrelevant, or incoherent speech; tremens caused by
cessation or reduction in alcohol consumption, typically in alcoholics with 10 or
more years of heavy drinking. Clinical symptoms: tachycardia, sweating, and
hypertention, a coarse irregular tremor and delusions, vivid hallucinations, and
wild agitated behavior.
20. Beta-adrenergic stimulaton: Stimulation of G-proteins such as epinephrine and
norepinephrine, to stimulate sodium uptake by the kidney during fight or flight
response.
21. Glycognolysis: break down of glycogen to glucose by hydrolysis (digestion or
within lysosomes) or phosphorolysis (mobilization of glycogen as fuel).
22. Champion Trauma Score: A physiological scoring system, with high inter-rater
reliability and demonstrated accuracy in predicting death, scored from the first set
of date gathered on a patient admitted due to traumatic insult. It consists of
Glasgow Coma Scale, Systolic Blood Pressure, and Respiratory rate.
23. Injury Severity Score: anatomical scoring system that provides an overall score
for patients with multiple injuries. Each injury is assigned a score and is allocated
to one of six body regions (head, face, chest, abdomen, extremities, and external).
Only the highest score from each region is used. Three of the most severely
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injured body systems have their score squared and added together to produce the
ISS.
24. Phlebitis: Inflammation of a vein; a condition is marked by infiltration of the
coats of the vein and the formation of a thrombus.
25. Diabetic Ketoacidosis: acidosis accompanied of ketone bodies in the body tissues
and fluids, specifically when glucoses are extremely elevated due to poorly
controlled diabetes or new onset of diabetes.
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APPENDIX A
Table 1. Nutrition Support Service potassium repletion algorithm
These doses should NOT be used patients with renal impairment or adrenal
insufficiency.
Serum K
(mEq/L)

KCL Dosage (mEq)

Laboratory work

3.5 – 3.9

40 mEq X 1; increase in
IV’s/PN

Get BMP, Mg next AM

3.0 – 3.4

40 mEq X 2; increase in
IV’s/PN

Get BMP, Mg next AM; may wish
to get stat K 2 hours after second
40 mEq bolus especially if losses
are suspected to be high.
Reassess.

2.0 – 2.9

40 mEq X 3+; increase in
IV’s/PN

Get stat K 2 hours after second 40
mEq bolus and reassess; may
need 1-2 additional boluses;
repeat. Check serum Mg.
Reassess.

30

Table 2. Study subject demographics group one (n=41), patients receiving 40 mEq
potassium dose
Subject

Mean

Std deviation

38.7

13.5

56-100 kg

76 kg

15

19-33kg/m²

38.7

3.5

Dose K

43.341

1.543

Pre-K

3.660

0.216

Post K

3.737

0.360

Difference

0.071

0.374

Demographics

Subject
Demographic
Data

Male

36

Female

5

Age (years)

18-59

Race:
Caucasian

26

African American

14

Other/Hispanic

1

Weight
BMI
40 mEq K dose

n=41
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Table 3. Group 2 patients receiving 60 mEq KCL dose (n=8)
Demographic data and results.

Subject

Mean

Std deviation

42.1

11.5

45-100 kg

79kg

18

23-33kg/m²

25.9

3.8

N=8

Mean

Std deviation

Pre-K

3.500

0.214

Post K

3.763

0.342

Difference

-0.263

0.393

Demographics

Subject
Demographic
Data

Male

5

Female

3

Age (years)

25-29

Race:
Caucasian

6

African American

1

Other
Weight
BMI

60 mEq K dose

1
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Table 4. Group 3 patients receiving 80 mEq KCL (n=8)
Demographic Data and results.
Subject

Subject
Demographic

Mean

Std Deviation

45

12.6

41-91kg

63kg

18

BMI

16-28

22.5

4.9

80 mEq dose

N=8

Mean

Std Deviation

Pre K

3.337

0.130

Post K

3.900

0.602

Difference

-0.563

0.655

Demographics

Data
Male

4

Female

4

Age (years)

28-63

Race:
Caucasian

4

African American

3

Hispanic/other
Weight

1
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APPENDIX B
THE UNIVERSITY OF MEMPHIS
Institutional Review Board approval letter
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THE UNIVERSITY OF TENNESSEE
Institutional Review Board letter of approval
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THE REGIONAL MEDICAL CENTER AT MEMPHIS
Letter of study approval
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